- Home
- SOPH
SOPH
SOPHiA GENETICS SA
as 05-17-2024 4:00pm EST
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
| Founded: | 2011 | Country: | Switzerland |
| Employees: | N/A | City: | N/A |
| Market Cap: | 296.8M | IPO Year: | 2021 |
| Target Price: | $8.00 | AVG Volume (30 days): | 75.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.12 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.13 - $7.37 | Next Earning Date: | 05-07-2024 |
| Revenue: | $64,184,000 | Revenue Growth: | 26.68% |
| Revenue Growth (this year): | 30.44% | Revenue Growth (next year): | 26.82% |
Share on Social Networks:
Latest SOPHiA GENETICS SA News
SOPH Breaking Stock News: Dive into SOPH Ticker-Specific Updates for Smart Investing
PR Newswire
4 days ago
Klinikum Klagenfurt am Wörthersee is Live with SOPHiA GENETICS
Insider Monkey
6 days ago
SOPHiA GENETICS SA (NASDAQ:SOPH) Q1 2024 Earnings Call Transcript
Simply Wall St.
11 days ago
SOPHiA GENETICS First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Zacks
12 days ago
Wall Street Analysts Think SOPHiA GENETICS (SOPH) Could Surge 64.95%: Read This Before Placing a Bet
GlobeNewswire
13 days ago
SOPHiA GENETICS Reports First Quarter 2024 Results
GlobeNewswire
20 days ago
SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference
GlobeNewswire
a month ago
SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024
MT Newswires
a month ago